The Firm recently represented the initial purchasers in connection with an offering by a subsidiary of Bausch Health Companies Inc. (“BHC”) of $4.4 billion aggregate principal amount of 10.000% senior secured notes due 2032 (the “Notes”) pursuant to Rule 144A and Regulation S.
In addition, the Firm represented the lenders in connection with BHC’s entry into new senior secured credit facilities consisting of (i) a $500 million 5-year senior secured revolving credit facility and (ii) a $3.0 billion 5.5-year senior secured term loan B facility.
BHC is a global, diversified specialty pharmaceutical and medical device company that develops, manufactures and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter products and aesthetic medical devices.
The Simpson Thacher team included John C. Ericson, John G. O’Connell, Patrick Baron, Traci Biedermann, Jieun Lim, Joseph Hahn, Olivia Pepper and Leandra Kede Yomo (Capital Markets); Jessica Tuchinsky, Michael Ratay, Kyle Nelson, Joel Kushner, In Young Kim and Colin Dennis (Credit); Sandy Qusba (Restructuring); Jon Pall (Collateral); Courtney Welshimer, Alysha Sekhon, Paige Brinton and Christina Breitbeil (Intellectual Property); Vanessa Burrows and Jacob Madden (Healthcare); Michael Mann (Tax); Jeanne Annarumma, Ryan Stott and Pasco Struhs (Executive Compensation and Employee Benefits); and Andrew Pagliughi (Blue Sky).